The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease
详细信息 查看全文
- 作者：Jim Young ; Nina Weis ; Harald Hofer ; William Irving ; Ola Weiland…
- 关键词：Daclatasvir ; Direct ; acting antivirals ; Effectiveness ; Hepatitis C ; Sofosbuvir
- 刊名：BMC Infectious Diseases
- 出版年：2017
- 出版时间：December 2017
- 年：2017
- 卷：17
- 期：1
- 全文大小：722KB
- 刊物主题：Infectious Diseases; Parasitology; Medical Microbiology; Tropical Medicine; Internal Medicine;
- 出版者：BioMed Central
- ISSN：1471-2334
- 卷排序：17
文摘
BackgroundThere is limited evidence for the effectiveness of daclatasvir in patients whose hepatitis C threatens their life expectancy. The Named Patient Program in Europe included patients with advanced chronic hepatitis C, a life expectancy of less than 12 months and no other treatment options.